TWI889038B - Microfluidic particle sorter - Google Patents
Microfluidic particle sorter Download PDFInfo
- Publication number
- TWI889038B TWI889038B TW112146335A TW112146335A TWI889038B TW I889038 B TWI889038 B TW I889038B TW 112146335 A TW112146335 A TW 112146335A TW 112146335 A TW112146335 A TW 112146335A TW I889038 B TWI889038 B TW I889038B
- Authority
- TW
- Taiwan
- Prior art keywords
- deterministic
- sample
- displacement column
- transverse displacement
- column array
- Prior art date
Links
Images
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Separation Of Solids By Using Liquids Or Pneumatic Power (AREA)
Abstract
Description
本發明是有關於一種微流體晶片,特別是指一種基於確定性橫向位移技術以進行微粒分選的微流體晶片。The present invention relates to a microfluidic chip, and more particularly to a microfluidic chip for particle sorting based on deterministic lateral displacement technology.
目前,用於檢體中之循環腫瘤細胞 (CTC,Circulating Tumor CeL)之篩選的常見技術,為基於抗體的CTC富集(CTC enrichment)分離方法。在CTC富集分離方法中,正向分選方法(positive selection)是使用EpCAM和表面抗體來捕獲CTC,雖然效率更高,但該方法可能會損失低抗原表現的腫瘤細胞。負向分選方法(negative selection)是使用 CD45/14等標誌(markers)去除檢體中之非目標細胞,例如去除白血球細胞(WBC),雖然高效率和高 CTC 回收率,但 CD/14/45/等標誌也會除去已表達的癌症標記細胞,且移除大量的白血球細胞所需抗體數量不少,成本較高。另一種CTC富集方法,是基於過濾器或微孔裝置的過濾方法,雖然可用以捕獲CTCs、突變細胞與CTC 簇(clusters),但純度低,且因過濾時的剪切應力高,會導致捕獲的細胞活力降低。其他CTC富集方法還有微流體晶片分選方法,例如基於介電泳的微流體晶片,及DLD(微流體確定性橫向位移,deterministic lateral)分離等方法。其中,介電泳微流體晶片雖然具有較高的CTC分選純度,但因為低流量與具有較低離子濃度介質溶液需求,以致於檢體需經大幅度稀釋處理,會增加檢體樣品體積與分選時間。DLD分離方法雖然也具有較高的CTC分選純度,且不需考慮介質離子濃度問題,但DLD分離方法並無法用以分離和CTC相似粒徑的其它細胞(例如白血球細胞)。所以目前的DLD分離技術尚有改進的空間。Currently, the common technology used to screen circulating tumor cells (CTCs) in samples is antibody-based CTC enrichment and separation methods. In the CTC enrichment and separation method, the positive selection method uses EpCAM and surface antibodies to capture CTCs. Although it is more efficient, this method may lose tumor cells with low antigen expression. Negative selection uses markers such as CD45/14 to remove non-target cells in the sample, such as white blood cells (WBC). Although it has high efficiency and high CTC recovery rate, CD/14/45/ and other markers will also remove cells that have expressed cancer markers, and the number of antibodies required to remove a large number of white blood cells is not small, and the cost is high. Another CTC enrichment method is a filtration method based on filters or microporous devices. Although it can be used to capture CTCs, mutant cells and CTC clusters, it has low purity and the high shear stress during filtration will lead to reduced viability of the captured cells. Other CTC enrichment methods include microfluidic chip sorting methods, such as dielectrophoresis-based microfluidic chips and DLD (deterministic lateral) separation methods. Among them, although the dielectrophoresis microfluidic chip has a higher CTC sorting purity, due to the low flow rate and the need for a medium solution with a lower ion concentration, the specimen needs to be significantly diluted, which will increase the specimen sample volume and sorting time. Although the DLD separation method also has a higher CTC sorting purity and does not need to consider the medium ion concentration problem, the DLD separation method cannot be used to separate other cells with a similar particle size to CTC (such as white blood cells). Therefore, the current DLD separation technology still has room for improvement.
因此,本發明的目的,即在提供一種能改善先前技術的至少一個缺點的微流體微粒分選器。Therefore, an object of the present invention is to provide a microfluidic particle sorter that can improve at least one disadvantage of the prior art.
於是,本發明微流體微粒分選器,適用於透過確定性橫向位移技術分選檢體液中的目標微粒與非目標微粒。該微流體微粒分選器包含一個晶片本體,及至少一個設置在該晶片本體中的第一確定性橫向位移柱陣列。Therefore, the microfluidic particle sorter of the present invention is suitable for sorting target particles and non-target particles in a sample liquid by using a deterministic lateral displacement technique. The microfluidic particle sorter comprises a chip body and at least one first deterministic lateral displacement column array disposed in the chip body.
該晶片本體具有一個沿一長度方向延伸的微流道,該微流道具有相反之一個檢體注入端與一個檢體流出端,且具有在一寬度方向相反的一個第一側與一個第二側。The chip body has a micro-channel extending along a length direction. The micro-channel has an opposite sample injection end and a sample outflow end, and has a first side and a second side opposite in a width direction.
該至少一第一確定性橫向位移柱陣列設置在該微流道中,包括多個沿該長度方向排列,並往該檢體流出端依序朝該第二側橫向偏移一預定距離(Δd)的第一橫向位移柱列。每一該第一橫向位移柱列具有多個直立設置並沿該寬度方向W間隔排列的第一裂柱。該等第一裂柱相配合於該微流道中界定出多個沿該寬度方向排列且相互連通,並沿該長度方向朝該檢體流出端偏斜延伸靠向該第二側的導引流道。每一該第一裂柱具有一個朝向該檢體注入端的迎水側,與一個朝向該檢體流出端的背水側,且每一該第一裂柱具有兩個間隔相向並相配合界定出該迎水側與該背水側的豎切柱體部,且該等豎切柱體部相配合界定出一個從該迎水側延伸至該背水側,並可用以供所述非目標微粒形變後通過的第一微間隙。每一該第一微間隙與該長度方向相夾一偏斜角度θ1,並往該第二側偏斜地朝該檢體流出端方向延伸,1∘≤θ1≤89∘。The at least one first deterministic transverse displacement column array is disposed in the microfluidic channel, and includes a plurality of first transverse displacement column arrays arranged along the length direction and sequentially offset laterally by a predetermined distance (Δd) toward the second side toward the sample outflow end. Each of the first transverse displacement column arrays has a plurality of first split columns arranged upright and arranged at intervals along the width direction W. The first split columns cooperate with the microfluidic channel to define a plurality of guide channels arranged along the width direction and interconnected, and extending obliquely toward the sample outflow end and toward the second side along the length direction. Each of the first split columns has a water-incoming side facing the sample injection end and a water-repelling side facing the sample outflow end, and each of the first split columns has two vertically cut column parts that are spaced and face each other and cooperate to define the water-incoming side and the water-repelling side, and the vertically cut column parts cooperate to define a first micro-gap extending from the water-incoming side to the water-repelling side and can be used for the non-target particles to pass through after deformation. Each of the first micro-gap is offset from the length direction by an angle θ1, and extends obliquely toward the second side toward the sample outflow end, 1∘≤θ1≤89∘.
本發明之功效在於:透過該第一確定性橫向位移柱陣列的每一該第一裂柱具有該第一微間隙的結構設計,除了可透過該等第一裂柱之排列結構設計來分選不同粒徑之所述目標微粒與所述非目標微粒外,還可利用該等第一裂柱之該等第一微間隙能供較大粒徑之所述非目標微粒透過形變方式擠過的設計,達到分選粒徑相近但形變能不同之所述目標微粒與所述非目標微粒的效果。The effect of the present invention lies in that: through the structural design that each of the first split columns of the first deterministic lateral displacement column array has the first micro-gap, in addition to being able to sort the target particles and the non-target particles of different particle sizes through the arrangement structural design of the first split columns, the first micro-gap of the first split columns can also be used to allow the non-target particles of larger particle sizes to be squeezed through by deformation, thereby achieving the effect of sorting the target particles and the non-target particles of similar particle sizes but different deformation energies.
在本發明被詳細描述前,應當注意在以下的說明內容中,類似的元件是以相同的編號來表示。Before the present invention is described in detail, it should be noted that similar components are represented by the same reference numerals in the following description.
參閱圖1、2、3,本發明微流體微粒分選器200的一個第一實施例,適用於透過確定性橫向位移技術(Deterministic Lateral Displacement,DLD)進行檢體液中之目標微粒901(圖未示)與非目標微粒902(圖未示)的分選。所述檢體液例如但不限於血液、胸水、腹水、尿液或其它體液的稀釋檢體等。所述目標微粒901例如但不限於循環腫瘤細胞 (CTCs,Circulating Tumor Cells)、腫瘤雜合細胞(THCs, Tumor Hybrid Cells)等,最小粒徑為Dt。所述非目標微粒902例如但不限於可產生形變之白血球、紅血球等血球細胞,所述非目標微粒902形變後之窄側的最大寬度為Ddnt,其中,Dt>Ddnt。Referring to Figs. 1, 2, and 3, a first embodiment of the
該微流體微粒分選器200包含一個晶片本體3,及設置在該晶片本體3中的多個第一確定性橫向位移柱陣列4與多個第二確定性橫向位移柱陣列5。The
必須說明的是,由於該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5之結構都是微米尺寸等級,所以圖式所示之各構件結構尺寸都僅為示意,實施時當不以圖式比例為限。It must be explained that, since the structures of the first deterministic lateral displacement column arrays 4 and the second deterministic lateral displacement column arrays 5 are both at the micron level, the structural dimensions of each component shown in the drawings are only for reference and are not limited to the scale of the drawings during implementation.
該晶片本體3內部具有一個微流道33、一個檢體液注入通道34、一個緩衝液注入通道35、一個廢液流出通道36,及一個目標微粒收集通道37。The
在本第一實施例中,該晶片本體3是透過微機電(Microelectromechanical Systems,MEMS)製程製作的一種微流體晶片,包括一個基板31,及一個疊置在該基板31上且底面凹設有凹槽與穿孔的蓋板32,該基板31會與該蓋板32之所述凹槽與穿孔相配合界定出所述流道與通道。該基板31與該蓋板32之製作材料例如但不限於PDMS(聚矽氧烷,polydimethylsiloxane)、矽膠彈性體、矽晶材料、玻璃、PMMA(poly (methyl methacrylate,聚甲基丙烯酸甲酯)、COC(Cyclic olefin copolymer,環狀烯烴聚合物))與PC(Polycarbonate,聚碳酸酯)等。由於該晶片本體3的製作為現有技術,且其層狀結構的材料類型眾多,因此不再詳述,且不以上述材料為限。In the first embodiment, the
該微流道33是沿一長度方向L前後水平延伸,具有沿該長度方向L相間隔的一個檢體注入端333與一個檢體流出端334,且具有沿一水平正交於該長度方向L之寬度方向W相背的一個第一側331與一個第二側332。該微流道33還具有兩個沿該寬度方向W相間隔且分別鄰近該第一側331與該第二側332之分選區間335,及一個介於該等分選區間335之間的匯集區間336。The microchannel 33 extends horizontally back and forth along a length direction L, and has a sample injection end 333 and a sample outflow end 334 spaced apart along the length direction L, and has a first side 331 and a second side 332 opposite to each other along a width direction W horizontally orthogonal to the length direction L. The microchannel 33 also has two sorting sections 335 spaced apart along the width direction W and adjacent to the first side 331 and the second side 332, respectively, and a collection section 336 between the sorting sections 335.
該檢體液注入通道34與該緩衝液注入通道35是連通於該檢體注入端333,且都具有外露在該晶片本體3頂側的開口。該檢體液注入通道34具有兩個以其一端相連通,而以其另外一端分別連通於該等分選區間335的檢體液注入區段341,可用以將所述檢體液引流注入該等分選區間335。該緩衝液注入通道35間隔位於該等檢體液注入區段341之間,並連通於該匯集區間336,可用以將所述緩衝液引流注入該匯集區間336。The sample
該廢液流出通道36與該目標微粒收集通道37是連通於該微流道33的該檢體流出端334,且都具有外露在該晶片本體3頂側的開口。該廢液流出通道36具有兩個以其一端相連通,而以其另一端分別連通於該等分選區間335的廢液流出區段361,可用以將來自該等分選區間335的液體引流出該晶片本體3外。該目標微粒收集通道37連通於該匯集區間336,而介於該等廢液流出區段361之間,該目標微粒收集通道37可用以把來自該匯集區間336的液體引流出該晶片本體3外。The waste
參閱圖2、3,該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5都連接在該基板31與該蓋板32間,且左右鏡像對稱地分別設置在該微流道33的該等分選區間335內,而分別鄰近該第一側331與該第二側332。且該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5都是沿該長度方向L往該檢體流出端334依序間隔排列。2 and 3, the first deterministic transverse displacement column arrays 4 and the second deterministic transverse displacement column arrays 5 are connected between the
由於該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5之結構是呈左右鏡像對稱狀,為方便說明,以下是以該等第一確定性橫向位移柱陣列4的其中一個為例進行結構說明。Since the structures of the first deterministic lateral displacement column arrays 4 and the second deterministic lateral displacement column arrays 5 are bilaterally mirror-symmetrical, for the convenience of explanation, the following structural description is made by taking one of the first deterministic lateral displacement column arrays 4 as an example.
參閱圖3、4、5,該第一確定性橫向位移柱陣列4包括多個沿該長度方向L間隔平行排列的第一橫向位移柱列41。該等第一橫向位移柱列41在該長度方向L的排列間距為D1。每一該第一橫向位移柱列41具有多個上下延伸,並沿該寬度方向W左右間隔排列之柱狀的第一裂柱410,且相鄰兩個該第一裂柱410在該寬度方向W的間距為D2,D2≧D1。每一該第一橫向位移柱列41之兩相鄰的該第一裂柱410的中心間距為λ。其中,0.33<Dt/D2<1.2,目標微粒901之粒徑需大於0.33D2,才能產生確定性橫向位移作用,但目標微粒901之粒徑不大於橫向相鄰之兩第一裂柱410或兩個第二裂柱510的間隙的1.2倍,否則目標微粒901會卡住。Referring to FIGS. 3, 4, and 5, the first deterministic transverse displacement column array 4 includes a plurality of first transverse displacement column rows 41 arranged in parallel and spaced apart along the length direction L. The arrangement spacing of the first transverse displacement column rows 41 in the length direction L is D1. Each of the first transverse displacement column rows 41 has a plurality of columnar
此外,每一該第一確定性橫向位移柱陣列4之該等第一橫向位移柱列41是往該檢體流出端334依序朝該第二側332橫向偏移一預定距離(Δd)。每一該第一確定性橫向位移柱陣列4之該等第一橫向位移柱列41的數量,是設計成會使排序第一的該第一橫向位移柱列41,相對排序最後的該第一橫向位移柱列41往該第二側332方向偏移該λ距離。其中,Δd/λ代表裂柱橫向位移的傾斜角度(θ3)。每一該第一確定性橫向位移柱陣列4的該等第一裂柱410會相配合於對應之該分選區間335內界定出多個左右排列且彼此橫向連通,並由前往後朝該匯集區間336偏斜延伸的導引流道416。且因該等第一橫向位移柱列41之橫向偏移結構設計,該等第一確定性橫向位移柱陣列4的該等導引流道416會左右錯位地前後連通。In addition, the first transverse displacement column rows 41 of each first deterministic transverse displacement column array 4 are sequentially shifted laterally toward the second side 332 toward the sample outflow end 334 by a predetermined distance (Δd). The number of the first transverse displacement column rows 41 of each first deterministic transverse displacement column array 4 is designed so that the first-ranked first transverse displacement column row 41 is shifted toward the second side 332 by the distance λ relative to the last-ranked first transverse displacement column row 41. Wherein, Δd/λ represents the tilt angle (θ3) of the transverse displacement of the split column. The
每一該第一裂柱410具有前後相背的一個迎水側411與一個背水側412,並具有兩個以其一個直立的豎切面414在該寬度方向W間隔相向,且相配合界定出該迎水側411與該背水側412的豎切柱體部413。每一該第一裂柱410的該等豎切面414相配合界定出一個自該迎水側411往後偏斜延伸至該背水側412的第一微間隙415,每一該第一微間隙415是與該長度方向L相夾一偏斜角度(θ1)地往後朝該第一側331偏斜。每一該第一微間隙415之寬度為Gp,是設計成可用以供所述非目標微粒902形變後通過。其中,1∘≤θ1≤89∘。Each of the
在本第一實施例中,該等第一裂柱410是呈圓柱狀,該等豎切柱體部413是呈俯視結構對稱之半圓柱狀,該等第一微間隙415的該等偏斜角度(θ1)相同,θ1=8∘。In the first embodiment, the
參閱圖3、5、6,每一該第二確定性橫向位移柱陣列5包括多個第二橫向位移柱列51,相鄰兩個該第二橫向位移柱列51在該長度方向L的排列間距為D1。每一該第二橫向位移柱列51具有多個第二裂柱510,相鄰兩個該第二裂柱510在該寬度方向W的間距為D2,D2≧D1,且0.33<Dt/D2<1.2。每一該第二橫向位移柱列51之兩相鄰的該第二裂柱510的中心間距為λ。Referring to FIGS. 3, 5, and 6, each of the second deterministic transverse displacement column arrays 5 includes a plurality of second transverse displacement column rows 51, and the arrangement spacing between two adjacent second transverse displacement column rows 51 in the length direction L is D1. Each of the second transverse displacement column rows 51 has a plurality of
每一該第二確定性橫向位移柱陣列5之該等第二橫向位移柱列51是往該檢體流出端334依序朝該第一側331橫向偏移一預定距離(Δd)。每一該第二確定性橫向位移柱陣列5之該等第二橫向位移柱列51的數量,是設計成會使排序第一的該第二橫向位移柱列51,相對排序最後的該第二橫向位移柱列51往該第一側331方向偏移λ距離。每一第二確定性橫向位移柱陣列5的該等第二裂柱510會相配合於對應之該分選區間335內界定出多個左右排列且彼此橫向連通,並由前往後朝該匯集區間336偏斜延伸的導引流道516。且因該等第二橫向位移柱列51之橫向偏移結構設計,該等第二確定性橫向位移柱陣列5的該等導引流道516會左右錯位地前後連通。The second transverse displacement column rows 51 of each second deterministic transverse displacement column array 5 are sequentially offset laterally by a predetermined distance (Δd) toward the first side 331 toward the sample outflow end 334. The number of the second transverse displacement column rows 51 of each second deterministic transverse displacement column array 5 is designed so that the first-ranked second transverse displacement column row 51 is offset by a distance λ toward the first side 331 relative to the last-ranked second transverse displacement column row 51. The
每一該第二裂柱510具有前後相背的一個迎水側511與一個背水側512,並具有兩個以其一個直立的豎切面514在該寬度方向W間隔相向,並相配合界定出該迎水側511與該背水側512的豎切柱體部513。每一該第二裂柱510的該等豎切面514相配合界定出一個自該迎水側511往後偏斜延伸至該背水側512的第二微間隙515。每一該第二微間隙515是與該長度方向L相夾一偏斜角度(θ2)地往後朝該第二側332偏斜。每一該第二微間隙515之寬度為Gp,可用以供所述非目標微粒902形變後通過。其中, 1∘≤θ2≤89∘。Each of the
在本第一實施例中,該等第二裂柱510是呈圓柱狀,且該等豎切柱體部513是呈俯視結構對稱之半圓柱狀,該等第二微間隙515的該等偏斜角度(θ2)相同,θ2=8∘。In the first embodiment, the
參閱圖2、3、5,本發明微流體微粒分選器200用以透過確定性橫向位移技術來進行所述檢體液(例如血液檢體)中之所述目標微粒901(例如循環腫瘤細胞)與非目標微粒902(例如血球細胞)的分選時,可持續從該緩衝液注入通道35將所述緩衝液注入該匯集區間336,以及從該檢體液注入通道34將所述檢體液注入該等分選區間335。使所述緩衝液往後流向該目標微粒收集通道37,以及使所述檢體液往後流經該等分選區間335中的該等導引流道416、516,而從該等廢液流出區段361流出。2, 3, and 5, the
在所述檢體液與所述緩衝液流動過程中,因為所欲分選出的所述目標微粒901的粒徑大且形變幅度小,不易往遠離匯集區間336的方向橫移通過前後間隔之兩個該第一裂柱410或兩個該第二裂柱510的間隙,所以可利用該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5產生的確定性橫向位移效果,驅使所述目標微粒901沿所在該導引流道416或516往後位移,而進入下一個該第一確定性橫向位移柱陣列4或該第二確定性橫向位移柱陣列5中之對應連通的該導引流道416或516,進而更靠近該匯集區間336,或者是由所在之該導引流道416或516直接進入該匯集區間336中。於此同時,粒徑較小的所述非目標微粒902則容易往遠離匯集區間336的方向橫移通過前後間隔之兩個該第一裂柱410或兩個該第二裂柱510的間隙,所以會驅使所述非目標微粒902逐漸遠離該匯集區間336地往該第一側331與該第二側332偏移集中。然後,就可從該目標微粒收集通道37收集到分選出的所述目標微粒901,而其餘非目標微粒902則會被所述檢體液帶往該等廢液流出通道36。During the flow of the sample liquid and the buffer liquid, the target particles 901 to be separated have a large particle size and a small deformation amplitude, and are not easy to move laterally away from the collection interval 336 through the gap between the two
此外,在檢體液往後流動過程中,部分粒徑較小的非目標微粒902也會於碰撞到該等第一裂柱410的迎水側411或該等第二裂柱510的迎水側511時,直接通過或些微形變通過該等第一微間隙415或該等第二微間隙515,而往相鄰之該第一側331或該第二側332偏移。In addition, during the backward flow of the sample liquid, some non-target particles 902 with smaller particle sizes will directly pass through or slightly deform through the
當所述檢體液中存在粒徑類似所述目標微粒901之粒徑,且易於形變的所述非目標微粒902時,例如白血球細胞,所述非目標微粒902於往後碰撞到其中一該第一裂柱410的該第一微間隙415開口或其中一該第二裂柱510的該第二微間隙515開口時,會受所述檢體液之流力驅動,而形變擠入所在的該第一微間隙415或該第二微間隙515,並沿該第一微間隙415或該第二微間隙515之延伸方向位移通過,進而會往遠離該匯集區間336的該第一側331或該第二側332偏移。When the non-target particles 902, such as white blood cells, have a particle size similar to that of the target particles 901 and are easily deformed in the sample fluid, when the non-target particles 902 collide with the opening of the
藉此設計,就可用以將易於形變的其它大粒徑的所述非目標微粒902逐漸往遠離該匯集區間336的方向分離,而達到分離粒徑類似之所述目標微粒901與非目標微粒902的效果。This design can be used to gradually separate the non-target particles 902 of other large particle sizes that are easy to deform in a direction away from the gathering interval 336, thereby achieving the effect of separating the target particles 901 and non-target particles 902 of similar particle sizes.
本發明微流體微粒分選器200用以分選所述目標微粒901與所述非目標微粒902時,可根據所欲達到之所述目標微粒901的回收效果,進行每一該第一裂柱410之該第一微間隙415的寬度Gp,與每一該第二裂柱510之該第二微間隙515的寬度Gp的大小設計,而有以下兩種實施態樣。When the
第一實施態樣:高回收率模式(high recovery mode)。First implementation mode: high recovery mode.
所述高回收率模式,是指所述目標微粒901的回收最大化,可達到將所述檢體液中之大部分的所述目標微粒901都分選出來的效果。在此模式中,所述第一微間隙415與所述第二微間隙515的寬度設計為:0.2Dt<Gp<0.8Dt。The high recovery rate mode refers to maximizing the recovery of the target particles 901, and can achieve the effect of sorting out most of the target particles 901 in the sample liquid. In this mode, the width of the
第二種實施態樣:高回收純度模式(high purity mod)。The second implementation mode: high purity mode.
所述高回收純度模式,是指使該目標微粒收集通道37中收集之微粒中的目標微粒901純度最大化,也就是可將所述檢體液中之大部分的非目標微粒902分離至該等廢液流出區段361的效果。在此模式中,所述第一微間隙415與所述第二微間隙515的寬度設計為:Ddnt<Gp<0.8Dt。The high recovery purity mode is to maximize the purity of the target particles 901 in the particles collected in the target
舉例來說,如果所述目標微粒901的粒徑Dt=15 um,所述非目標微粒902無論原始多大,最大形變後之窄側寬度Ddnt<6 um,則將所述GP設計為6 um,D1=20 um,D2=32 um,Δd=0.9 um,λ=68 um。可用以驅使所述檢體液中之大多數的所述目標微粒901被橫向位移至該匯集區間336,而被分選出。For example, if the particle size Dt of the target particle 901 is 15 um, and the narrow side width Ddnt of the non-target particle 902 after maximum deformation is less than 6 um regardless of its original size, the GP is designed to be 6 um, D1=20 um, D2=32 um, Δd=0.9 um, and λ=68 um. This can be used to drive most of the target particles 901 in the sample liquid to be displaced laterally to the collection interval 336 and be sorted out.
若欲使所述目標微粒901回收率最大化,可將所述GP設計為3 um。藉此設計,會使大部分的所述目標微粒901被分選至該匯集區間336,但因為所述GP太小,所以會使部分的所述非目標微粒902無法形變通過,以致於部分粒徑較大的所述非目標微粒902也會一起被分選至該匯集區間336。If the recovery rate of the target particles 901 is to be maximized, the GP can be designed to be 3 um. With this design, most of the target particles 901 will be sorted into the collection section 336, but because the GP is too small, some of the non-target particles 902 will not be able to deform and pass through, so that some of the non-target particles 902 with larger particle sizes will also be sorted into the collection section 336.
若欲使所述目標微粒901之回收純度最佳化,則可將所述GP設計為12 um。藉此設計,可使大多數的所述非目標微粒902可輕易形變通過該等第一微間隙415與該等第二微間隙515,而被保留在該等分選區間335中,可將被分選至該匯集區間336的所述目標微粒901的純度提高,但相對的,也有機率會使所述目標微粒901因些微形變而穿越或卡在該等第一微間隙415及/或該等第二微間隙515,所以可能會造成部分所述目標微粒901未被分選至該匯集區間336。If the recovery purity of the target particles 901 is to be optimized, the GP can be designed to be 12 um. With this design, most of the non-target particles 902 can be easily deformed to pass through the
參閱圖5、7,在本第一實施例中,每一該第一裂柱410與每一該第二裂柱510之整體外型是設計成圓柱狀,而成對之該等豎切柱體部413、513是呈俯視結構對稱之半圓柱狀。但實施時,在本發明之另一實施態樣中,成對之該等豎切柱體部413、513之大小也可以設計成俯視結構不對稱,使成對之該等豎切柱體部413、513呈不對稱切圓柱狀(如圖7所示)。Referring to FIGS. 5 and 7 , in the first embodiment, the overall shape of each
當該等第一裂柱410與該等第二裂柱510之該等豎切柱體部413、513呈俯視結構不對稱狀時,可以呈圖7所示之該等第一確定性橫向位移柱陣列4的設置方式,使相對較小的該豎切柱體部413鄰近該匯集區間336,也可以呈圖7所示之該等第二確定性橫向位移柱陣列5的設置方式,使相對較大的該豎切柱體部513鄰近該匯集區間336,只要所述第一微間隙415與所述第二微間隙515的前側開口位在對應之該第一裂柱410之該迎水側411與該第二裂柱510之該迎水側511,都可以用以導引形變後之所述非目標微粒902往後通過。When the vertically cut
此外,實施時,該等第一裂柱410之該等第一微間隙415的偏斜角度,以及該等第二裂柱510之該等第二微間隙515的偏斜角度,並不以相同為必要,同一該第一橫向位移柱列41之該等第一裂柱410的該等第一微間隙415的偏斜角度也可以不同,同一該第二橫向位移柱列51之該等第二裂柱510的該等第二微間隙515的偏斜角度也可以不同。In addition, during implementation, the deflection angles of the first
再者,在本第一實施例中,該等第一裂柱410與該等第二裂柱510都是設計成圓柱狀,但實施時,在本發明之其它實施態樣中,該等第一裂柱410與該等第二裂柱510也可設計成其它幾何形狀,例如但不限於圖8~圖14所示之形狀,只要該第一裂柱410具有一個迎水側411與一個背水側412,該第二裂柱510具有一個迎水側511與一個背水側512,且每一該第一微間隙415與每一該第二微間隙515是從對應之該迎水側411、511背離該匯集區間336地往後偏斜延伸至該對應之該背水側412、512,就可用以供往後移動之非目標微粒902透過形變方式通過,而達到將所述非目標微粒902導引偏離該匯集區間336的效果。Furthermore, in the first embodiment, the
以癌細胞(CTCs)做為目標微粒,緩衝液為PBS(Phosphate buffered saline),會以PBS緩衝液對健康人血液進行10倍稀釋後,加入特定數量的癌細胞,藉以製成檢體液,並以本發明微流體微粒分選器200進行癌細胞與血球細胞(WBCs與RBCs)的分選測試。其中,該微流體微粒分選器200之結構參數如下:D1=20 um,D2=32 um,Δd=0.9 um,λ=68 um。該等第一裂柱410與該等第二裂柱510都為非對稱斜切。每一該第一微間隙415與每一該第二微間隙515之微間隙Gp為6 um。該等第一微間隙415與該等第二微間隙515的偏斜角度都為8∘。檢體液的流速為12 mL/hr,從該緩衝液注入通道35注入的所述緩衝液的流速為85 mL/hr。Cancer cells (CTCs) are used as target particles, and the buffer is PBS (Phosphate buffered saline). After the healthy person's blood is diluted 10 times with PBS buffer, a specific amount of cancer cells is added to make a sample solution, and the
圖15~圖17為本發明微流體微粒分選器200沿所述檢體液之流動方向800之不同部位的顯微影像圖。FIG. 15 to FIG. 17 are microscopic images of different parts of the
從圖15、16顯示內容可知,癌細胞(CTCs)會遷移集中至該匯集區間336,而血球細胞(WBCs與RBCs)被側向導引遠離該匯集區間336。部分白血球細胞(WBCs)會變形擠過遇到之該第一裂柱410的該第一微間隙415或該第二裂柱510的該第二微間隙515。參閱圖17,當癌細胞與血球細胞通過最後的該第一確定性橫向位移柱陣列4與該第二確定性橫向位移柱陣列5後,可以明顯看到癌細胞與血球細胞構成的檢體流會被明顯分開,而確實可從血液檢體中分離出欲取得之癌細胞。As shown in FIGS. 15 and 16 , cancer cells (CTCs) migrate and concentrate in the collection zone 336, while blood cells (WBCs and RBCs) are laterally guided away from the collection zone 336. Some white blood cells (WBCs) deform and squeeze through the
接下來,進行檢體純化試驗。以A549/GFP肺癌細胞做為目標微粒,將特定數量的肺癌細胞混合加入血液檢體中,藉以製成blood-A549檢體液。並以本發明微流體微粒分選器對所述blood-A549檢體液中的A549/GFP肺癌細胞進行分選純化試驗,且以傳統DLD結構設計之分選器對相同的blood-A549檢體液進行所述A549/GFP肺癌細胞的分選純化試驗。Next, a sample purification test was performed. A549/GFP lung cancer cells were used as target particles, and a specific number of lung cancer cells were mixed and added to a blood sample to prepare a blood-A549 sample solution. The microfluidic particle sorter of the present invention was used to sort and purify the A549/GFP lung cancer cells in the blood-A549 sample solution, and the sorter with a traditional DLD structure design was used to sort and purify the A549/GFP lung cancer cells in the same blood-A549 sample solution.
兩種分選器會各別進行相同之blood-A549檢體液的分選處理,每次使用之blood-A549檢體液為5 ml。分選處理後,會透過顯微影像分析每次分選後檢體液中之A549/GFP肺癌細胞與血球細胞的數量,藉以統計分析回收率與樣本純化率。The two sorters will be used to sort the same blood-A549 sample solution, with 5 ml of blood-A549 sample solution used each time. After sorting, the number of A549/GFP lung cancer cells and blood cells in the sample solution after each sorting will be analyzed by microscopic imaging to statistically analyze the recovery rate and sample purification rate.
在本試驗中,緩衝液為PBS,會以PBS緩衝液對健康人血液進行10倍稀釋後,加入29~91顆A549/GFP肺癌細胞,製成所述blood-A549檢體液。從該等檢體液注入區段341注入所述blood-A549檢體液的流速為12 mL/hr,從該緩衝液注入通道35注入的所述緩衝液的流速為85 mL/hr。In this experiment, the buffer is PBS. After the healthy human blood is diluted 10 times with PBS buffer, 29 to 91 A549/GFP lung cancer cells are added to prepare the blood-A549 sample solution. The flow rate of the blood-A549 sample solution injected from the sample solution injection section 341 is 12 mL/hr, and the flow rate of the buffer solution injected from the buffer
傳統DLD結構設計的分選器與本發明微流體微粒分選器200之結構大致相同,差異在於:傳統DLD分選器不具有本發明之該等第一裂柱410與該等第二裂柱510之所述微間隙結構。本發明之該微流體微粒分選器200的結構參數如下:D1=20 um,D2=32 um,Δd=0.9 um,λ=68 um。該等第一裂柱410與該等第二裂柱510都為非對稱斜切。每一該第一微間隙415與每一該第二微間隙515之微間隙Gp為6 um。該等第一微間隙415與該等第二微間隙515的偏斜角度都為8∘。The structure of the sorter with the traditional DLD structure design is roughly the same as that of the
參閱圖18、19,為經過所述兩種分選器分選處理後之含有所述肺癌細胞的分選後檢體液的顯微影像,綠色螢光顆粒為A549/GFP肺癌細胞,其餘顆粒為血球細胞。相較於傳統DLD分選器的分選結果,本發明微流體微粒分選器200之分選後檢體液中的血球細胞明顯較少,本發明微流體微粒分選器200對於檢體液的純化率可大幅提升1~2 logs。See Figures 18 and 19, which are microscopic images of the sample solution containing the lung cancer cells after sorting by the two sorters. The green fluorescent particles are A549/GFP lung cancer cells, and the remaining particles are blood cells. Compared with the sorting results of the traditional DLD sorter, the blood cells in the sample solution after sorting by the
由表1之統計結果顯示,本發明微流體微粒分選器200對於A549/GFP肺癌細胞捕獲回收率平均達86% (N=8),最高回收率達95.5%,最低回收率達78.1%。
參閱圖20,本發明微流體微粒分選器200之一個第二實施例與該第一實施例差異處在於:未設置該等第二確定性橫向位移柱陣列。為方便說明,以下將僅針對各個實施例間之差異處進行描述。Referring to FIG. 20 , a second embodiment of the
在本第二實施例中,該微流體微粒分選器200包含該晶片本體3,及前後排列設置在該晶片本體3之該微流道33中的該等第一確定性橫向位移柱陣列4。該晶片本體3的該檢體液注入通道34與該緩衝液注入通道35分別鄰近該微流道33之該第一側331與該第二側332,該廢液流出通道36與該目標微粒收集通道37分別鄰近該第一側331與該第二側332。In the second embodiment, the
該等第一確定性橫向位移柱陣列4是前後排列地設置在該微流道33中。每一該第一裂柱410的該第一微間隙415是從該迎水側411往後朝該第二側332偏斜地延伸至該背水側412。The first deterministic transverse displacement column arrays 4 are arranged in a front-to-back arrangement in the microchannel 33. The first
本第二實施例用以進行所述目標微粒901與所述非目標微粒902的分選的方法相同於該第一實施例,所以不再詳述。The method for separating the target particles 901 and the non-target particles 902 in the second embodiment is the same as that in the first embodiment, so it will not be described in detail.
實施時,同樣可透過上述第一實施態樣與該第二實施態樣之結構設計,來分別提高回收率與回收純度。During implementation, the recovery rate and the recovery purity can be improved respectively through the structural design of the first embodiment and the second embodiment.
此外,在該第二實施例的另一實施態樣中,也可僅設置一個該第一確定性橫向位移柱陣列4,同樣可用以進行所述目標微粒901與所述非目標微粒902的分選處理。In addition, in another implementation of the second embodiment, only one first deterministic lateral displacement column array 4 may be provided, which can also be used to perform the sorting process of the target particles 901 and the non-target particles 902.
參閱圖3、21,本發明微流體微粒分選器200之一個第三實施例與該第一實施例差異處在於:該晶片本體3的結構設計,以及該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5的設置方式。3 and 21 , a third embodiment of the
在本第三實施例中,該晶片本體3內部具有兩個上下間隔設置且前後兩端連通該微流道33。晶片本體3包括一個基板31,及兩個上下層疊地設置在該基板31上的蓋板32。位於下層之該蓋板32會與該基板31相配合界定出其中一個該微流道33,上下層疊之該等蓋板32會相配合界定出其中另一個該微流道33。該檢體液注入通道34與該緩衝液注入通道35上下連通該等微流道33之該等檢體注入端333,該廢液流出通道36與該目標微粒收集通道37上下連通該等微流道33之該等檢體流出端334。In the third embodiment, the
該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5是左右鏡像對稱地設置該等微流道33中。因為每一該微流道33中之該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5的分布設置結構,相同於該第一實施例,因此不再詳述。The first deterministic transverse displacement column arrays 4 and the second deterministic transverse displacement column arrays 5 are disposed in the microchannels 33 in a left-right mirror-symmetrical manner. Since the distribution and arrangement structure of the first deterministic transverse displacement column arrays 4 and the second deterministic transverse displacement column arrays 5 in each microchannel 33 is the same as that in the first embodiment, they will not be described in detail.
在本第三實施例中,是以疊置兩個該蓋板32以構成兩個該微流道33為例進行說明,但實施時,在本發明之其它實施態樣中,可增加該等蓋板32的數量以對應增加該等微流道33的數量,並於每一該微流道33設置該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5。In the third embodiment, two
透過層疊多個該蓋板32,藉以構成多個微流道33,並於每一該微流道33中設置該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5的結構設計,可用以進行大量檢體液之所述目標微粒901與所述非目標微粒902的分選處理,有助於提高處理效能。By stacking a plurality of
綜上所述,透過該等第一確定性橫向位移柱陣列4的每一該第一裂柱410具有該第一微間隙415的結構設計,除了可透過該等第一裂柱410之排列結構設計來分選不同粒徑之所述目標微粒901與所述非目標微粒902外,還可利用該等第一裂柱410之該等第一微間隙415能供較大粒徑之所述非目標微粒902透過形變方式擠過的設計,達到分選粒徑相近但形變能不同之所述目標微粒901與所述非目標微粒902的效果,進而有助於提高檢體液中之所述目標微粒901與各種粒徑的所述非目標微粒902的分選效率。In summary, through the structural design that each of the
本發明還可透過在該微流道33中設置左右鏡像對稱之該等第一確定性橫向位移柱陣列4與該等第二確定性橫向位移柱陣列5的結構設計,來更進一步提高所述目標微粒901與所述非目標微粒902的分選效率。此外,還可透過該等第一微間隙415與該等第二微間隙515的寬度尺寸設計,來提高所述目標微粒901之分選回收率或回收純度。The present invention can further improve the sorting efficiency of the target particles 901 and the non-target particles 902 by arranging the first deterministic transverse displacement column arrays 4 and the second deterministic transverse displacement column arrays 5 in left-right mirror image symmetry in the microchannel 33. In addition, the sorting recovery rate or recovery purity of the target particles 901 can be improved by designing the width size of the first
因此,本發明微流體微粒分選器200確實是一種相當創新的創作,確實能達成本發明的目的。Therefore, the
惟以上所述者,僅為本發明的實施例而已,當不能以此限定本發明實施的範圍,凡是依本發明申請專利範圍及專利說明書內容所作的簡單的等效變化與修飾,皆仍屬本發明專利涵蓋的範圍內。However, the above is only an embodiment of the present invention and should not be used to limit the scope of implementation of the present invention. All simple equivalent changes and modifications made according to the scope of the patent application of the present invention and the content of the patent specification are still within the scope of the present patent.
200:微流體微粒分選器 3:晶片本體 31:基板 32:蓋板 33:微流道 331:第一側 332:第二側 333:檢體注入端 334:檢體流出端 335:分選區間 336:匯集區間 34:檢體液注入通道 341:檢體液注入區段 35:緩衝液注入通道 36:廢液流出通道 361:廢液流出區段 37:目標微粒收集通道 4:第一確定性橫向位移柱陣列 41:第一橫向位移柱列 410:第一裂柱 411:迎水側 412:背水側 413:豎切柱體部 414:豎切面 415:第一微間隙 416:導引流道 5:第二確定性橫向位移柱陣列 51:第二橫向位移柱列 510:第二裂柱 511:迎水側 512:背水側 513:豎切柱體部 514:豎切面 515:第二微間隙 516:導引流道 800:流動方向 901:目標微粒 902:非目標微粒 200: Microfluidic particle sorter 3: Chip body 31: Substrate 32: Cover plate 33: Microchannel 331: First side 332: Second side 333: Sample injection end 334: Sample outflow end 335: Sorting interval 336: Converging interval 34: Sample liquid injection channel 341: Sample liquid injection section 35: Buffer liquid injection channel 36: Waste liquid outflow channel 361: Waste liquid outflow section 37: Target particle collection channel 4: First deterministic transverse displacement column array 41: First transverse displacement column array 410: First split column 411: Upstream side 412: Backward side 413: vertical section of the column 414: vertical section 415: first micro-gap 416: guide channel 5: second deterministic transverse displacement column array 51: second transverse displacement column array 510: second split column 511: water-facing side 512: water-receiving side 513: vertical section of the column 514: vertical section 515: second micro-gap 516: guide channel 800: flow direction 901: target particles 902: non-target particles
本發明的其他的特徵及功效,將於參照圖式的實施方式中清楚地呈現,其中: 圖1是一個立體圖,示意說明本發明微流體微粒分選器的一個第一實施例的結構; 圖2是一個不完整的側剖視圖,說明該第一實施例的結構; 圖3是一個不完整的俯視圖,示意說明該第一實施例的多個第一確定性橫向位移柱陣列與多個第二確定性橫向位移柱陣列在一個微流道中的布置方式; 圖4是一個立體圖,示意說明該第一實施例之一個第一裂柱的結構; 圖5是圖3之局部放大圖; 圖6是一個立體圖,示意說明該第一實施例之一個第二裂柱的結構; 圖7是類似圖5之視圖,說明該第一實施例之該等第一裂柱與該等第二裂柱之另一種實施態樣; 圖8~圖14是俯視圖,示意說明該第一實施例之所述第一裂柱與所述第二裂柱的其它實施態樣外型; 圖15~17為該第一實施例用以進行檢體液中之血球細胞與癌細胞之分選時,沿所述檢體液之流動方向的不同部位的顯微影像圖; 圖18為一個顯微影像圖,說明傳統DLD分選器對blood-A549檢體液中之A549/GFP肺癌細胞分選處理後之液體中的血球細胞數量; 圖19為一個顯微影像圖,說明該第一實施例對blood-A549檢體液中之A549/GFP肺癌細胞分選處理後之液體中的血球細胞數量; 圖20是一個俯視圖,示意說明本發明微流體微粒分選器的一個第二實施例之該等第一確定性橫向位移柱陣列在該微流道中的設置方式;及 圖21是一個不完整的側剖視圖,示意說明本發明微流體微粒分選器的一個第三實施例的多層微流道結構。 Other features and effects of the present invention will be clearly presented in the embodiments with reference to the drawings, wherein: FIG. 1 is a three-dimensional diagram schematically illustrating the structure of a first embodiment of the microfluidic particle sorter of the present invention; FIG. 2 is an incomplete side sectional view schematically illustrating the structure of the first embodiment; FIG. 3 is an incomplete top view schematically illustrating the arrangement of a plurality of first deterministic transverse displacement column arrays and a plurality of second deterministic transverse displacement column arrays of the first embodiment in a microfluidic channel; FIG. 4 is a three-dimensional diagram schematically illustrating the structure of a first split column of the first embodiment; FIG. 5 is a partial enlarged view of FIG. 3; FIG. 6 is a three-dimensional diagram schematically illustrating the structure of a second split column of the first embodiment; FIG. 7 is a view similar to FIG. 5, illustrating another embodiment of the first split columns and the second split columns of the first embodiment; FIG. 8 to FIG. 14 are top views, schematically illustrating the appearance of other embodiments of the first split column and the second split column of the first embodiment; FIG. 15 to FIG. 17 are microscopic images of different parts along the flow direction of the specimen liquid when the first embodiment is used to sort blood cells and cancer cells in the specimen liquid; FIG. 18 is a microscopic image, illustrating the number of blood cells in the liquid after the traditional DLD sorter sorts A549/GFP lung cancer cells in the blood-A549 specimen liquid; FIG. 19 is a microscopic image diagram illustrating the number of blood cells in the liquid after the A549/GFP lung cancer cells in the blood-A549 specimen liquid are sorted and processed in the first embodiment; FIG. 20 is a top view schematically illustrating the arrangement of the first deterministic transverse displacement column arrays in the microchannel of a second embodiment of the microfluidic particle sorter of the present invention; and FIG. 21 is an incomplete side sectional view schematically illustrating the multi-layer microchannel structure of a third embodiment of the microfluidic particle sorter of the present invention.
3:晶片本體 3: Chip body
33:微流道 33: Microchannel
331:第一側 331: First side
332:第二側 332: Second side
335:分選區間 335: Sorting interval
336:匯集區間 336: aggregation interval
4:第一確定性橫向位移柱陣列 4: First deterministic horizontal displacement column array
41:第一橫向位移柱列 41: First horizontal displacement column row
410:第一裂柱 410: The First Split Pillar
413:豎切柱體部 413: Vertically cut column part
415:第一微間隙 415: The first micro gap
416:導引流道 416: Guide channel
5:第二確定性橫向位移柱陣列 5: Second deterministic horizontal displacement column array
51:第二橫向位移柱列 51: Second horizontal displacement column row
510:第二裂柱 510: The Second Split Pillar
513:豎切柱體部 513: Vertically cut column part
515:第二微間隙 515: Second micro gap
516:導引流道 516: Guide channel
901:目標微粒 901: Target particles
902:非目標微粒 902: Non-target particles
Claims (15)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18/633,201 US20240351036A1 (en) | 2023-04-14 | 2024-04-11 | Microfluidic particle sorter |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363496086P | 2023-04-14 | 2023-04-14 | |
| US63/496,086 | 2023-04-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202443150A TW202443150A (en) | 2024-11-01 |
| TWI889038B true TWI889038B (en) | 2025-07-01 |
Family
ID=94377751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112146335A TWI889038B (en) | 2023-04-14 | 2023-11-29 | Microfluidic particle sorter |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI889038B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070196820A1 (en) * | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
| TW202045243A (en) * | 2019-06-05 | 2020-12-16 | 薩摩亞商曦醫生技股份有限公司 | Microfluidic device which can process great amount of liquid samples per a unit time and has good filtering effect |
| US20210114028A1 (en) * | 2018-01-19 | 2021-04-22 | International Business Machines Corporation | Microfluidic chips for particle purification and fractionation |
| JP2022052326A (en) * | 2020-09-23 | 2022-04-04 | シャープセミコンダクターイノベーション株式会社 | Flow channel device, in-fluid particle analysis system, and in-fluid particle sorting system |
| CN115209996A (en) * | 2019-12-28 | 2022-10-18 | Gpb科学有限公司 | Microfluidic cartridge for processing particles and cells |
-
2023
- 2023-11-29 TW TW112146335A patent/TWI889038B/en active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070196820A1 (en) * | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
| US20210114028A1 (en) * | 2018-01-19 | 2021-04-22 | International Business Machines Corporation | Microfluidic chips for particle purification and fractionation |
| TW202045243A (en) * | 2019-06-05 | 2020-12-16 | 薩摩亞商曦醫生技股份有限公司 | Microfluidic device which can process great amount of liquid samples per a unit time and has good filtering effect |
| CN115209996A (en) * | 2019-12-28 | 2022-10-18 | Gpb科学有限公司 | Microfluidic cartridge for processing particles and cells |
| JP2022052326A (en) * | 2020-09-23 | 2022-04-04 | シャープセミコンダクターイノベーション株式会社 | Flow channel device, in-fluid particle analysis system, and in-fluid particle sorting system |
Non-Patent Citations (1)
| Title |
|---|
| 期刊 Zongbin Liu et al Cascaded filter deterministic lateral displacement microchips for isolation and molecular analysis of circulating tumor cells and fusion cells Cascaded filter deterministic lateral displacement microchips for isolation and molecular analysis of circulating tumor cells and fusion cells 2021,21 Lab Chip 28 Jun 2021 2881-2891 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202443150A (en) | 2024-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11052392B2 (en) | Microfluidic device for cell separation and uses thereof | |
| CN107262171B (en) | Blood separation pretreatment chip and blood separation device | |
| CN111909828B (en) | Microfluidic chip suitable for capturing circulating tumor cells | |
| CN108660060B (en) | Microfluidic chip for enriching and purifying circulating tumor cells | |
| WO2019233303A1 (en) | Laterally-displaced micro-pillar array chip and use thereof | |
| WO2019128841A1 (en) | Spiral microchannel, use method thereof, and series/parallel-connected installation structure | |
| JP2006501449A5 (en) | ||
| KR101791671B1 (en) | Apparatus of Sorting and Aligning Micro-particles, and Method thereof | |
| KR20160069427A (en) | Apparatus for classifying micro-particles | |
| US11559808B2 (en) | Microfluidic device | |
| TWI804560B (en) | Microfluidic cellular device and methods of use thereof | |
| CN112553048B (en) | Cell sorting method and chip | |
| TWI889038B (en) | Microfluidic particle sorter | |
| US20140102948A1 (en) | High efficiency particle separating apparatus and method | |
| CN116727007B (en) | DLD micro-fluidic chip and method based on transit time sorting | |
| US20240351036A1 (en) | Microfluidic particle sorter | |
| JP6403190B2 (en) | Microchannel structure and particle separation method | |
| CN116713046A (en) | High-flux cell sorting micro-fluidic chip and manufacturing method thereof | |
| Mane et al. | Microfluidic systems for isolation of white blood cells: from design to practical applications | |
| WO2023189095A1 (en) | White blood cell capturing device | |
| CN112044479A (en) | Micro-channel device | |
| TWM583849U (en) | Microfluidic device | |
| WO2019114410A1 (en) | Target capturing device, manufacturing method therefor and target detection method | |
| CN223974071U (en) | An apparatus for sorting and enrichment | |
| CN118546745B (en) | Tumor cell separation and capture microfluidic chip and use method |